BC Cancer Lung Screening Program—first of its kind in Canada

BC Cancer has launched the Lung Screening Program, the first organized province-wide lung-screening program for high-risk individuals in the country. Lung cancer is the leading cause of cancer death in Canada and worldwide. In BC, seven people die of lung cancer every day. With 70% of all cases currently diagnosed at an advanced stage, the Lung Screening Program aims to detect lung cancer at an earlier stage, when treatment is more effective.

Lung screening involves a low-dose computed tomography (LDCT) scan of the lungs. A network of lung-screening sites has been established across BC within each health authority using existing CT equipment within hospitals. The scan takes less than 10 seconds and is not painful. Patients do not need to take any medications or receive any needles for this test. After a patient’s LDCT scan, a radiologist with expertise in early diagnosis will review the images taken at a designated reading site located within the patient’s health authority. A computer-assisted diagnostic tool and standardized reporting format will be used to improve consistency and accuracy of reading and recommendation. Results of the patient’s lung scan will be sent to the patient and their primary care provider.

Who is eligible for lung screening?

Lung screening is best for those who are at high risk for lung cancer and who are not experiencing any symptoms. This includes people who:

  • Are 55 to 74 years of age.
  • Currently smoke or have previously smoked.
  • Have a smoking history of 20 years or more.

Interested individuals can self-refer directly to the screening program. Primary care providers can encourage eligible patients to call the Lung Screening Program (1 877 717-5864) to complete a risk assessment over the phone to confirm their screening eligibility. A fax referral option is also available (referral form accessible through the Health Professionals link below).

Role of primary care providers

Primary care providers play an important role in the Lung Screening Program, including:

  • Supporting patients with their decision making and recommending lung screening when appropriate.
  • Providing smoking cessation pharmacotherapy support.
  • Providing follow-up for additional findings and support for abnormal results.

To learn more about the Lung Screening Program and to access helpful program resources, visit the Health Professionals page on BC Cancer’s website: www.screeningbc.ca/health-professionals.
—Sandy Zhang, MPH
Promotion Specialist, Prevention, Screening, Hereditary Cancer Program, BC Cancer


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Sandy Zhang, MPH. BC Cancer Lung Screening Program—first of its kind in Canada. BCMJ, Vol. 64, No. 6, July, August, 2022, Page(s) 253 - News.

Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.

For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org

BCMJ Guidelines for Authors

Leave a Reply